drugset / Trial / NCT00126685
Vaccine Therapy in Treating Patients With Stage IV Melanoma
Non-randomizedOpen-labelTreatment
Summary
RATIONALE: Vaccines made from a person's tumor cells and white blood cells may help the body build an effective immune response to kill tumor cells. PURPOSE: This phase I/II trial is studying the side effects of vaccine therapy and to see how well it works in treating patients with stage IV melanoma.
Timeline
- Start
- 2005-04
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | autologous tumor cell vaccine | Vaccine | — | Intravenous |
| Subject | therapeutic autologous dendritic cells | Vaccine | — | Intravenous |